Daniel G. Arkfeld

1.3k total citations
35 papers, 868 citations indexed

About

Daniel G. Arkfeld is a scholar working on Rheumatology, Psychiatry and Mental health and Surgery. According to data from OpenAlex, Daniel G. Arkfeld has authored 35 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 8 papers in Psychiatry and Mental health and 5 papers in Surgery. Recurrent topics in Daniel G. Arkfeld's work include Systemic Lupus Erythematosus Research (9 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Daniel G. Arkfeld is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Daniel G. Arkfeld collaborates with scholars based in United States and France. Daniel G. Arkfeld's co-authors include Samy Metyas, Glenn R. Ehresmann, William Stohl, Thi‐Sau Migone, David M. Hilbert, Dong Xu, Viktor Roschke, Howard A. Liebman, Susan Kovats and George R. Dodge and has published in prestigious journals such as The Journal of Immunology, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Daniel G. Arkfeld

30 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel G. Arkfeld United States 15 302 264 157 141 116 35 868
Marco Taglietti Italy 13 416 1.4× 198 0.8× 98 0.6× 117 0.8× 93 0.8× 19 704
Joëlle Goetz France 17 357 1.2× 334 1.3× 313 2.0× 175 1.2× 115 1.0× 58 1.1k
Cor L. Verweij Netherlands 12 233 0.8× 476 1.8× 65 0.4× 146 1.0× 100 0.9× 17 1.0k
Hirotsugu Ide Japan 16 312 1.0× 344 1.3× 113 0.7× 100 0.7× 56 0.5× 36 993
O Hübscher Argentina 14 257 0.9× 182 0.7× 285 1.8× 108 0.8× 137 1.2× 30 756
Laëtitia Le Pottier France 17 169 0.6× 440 1.7× 313 2.0× 68 0.5× 100 0.9× 33 893
Thomas McDonnell United Kingdom 17 356 1.2× 337 1.3× 52 0.3× 169 1.2× 87 0.8× 52 1.1k
Nancy Solowski United States 7 205 0.7× 261 1.0× 74 0.5× 86 0.6× 75 0.6× 11 699
Guadalupe Lima Mexico 19 266 0.9× 429 1.6× 118 0.8× 42 0.3× 69 0.6× 54 821
Daniel Aeberli Switzerland 18 218 0.7× 385 1.5× 134 0.9× 68 0.5× 45 0.4× 47 1.0k

Countries citing papers authored by Daniel G. Arkfeld

Since Specialization
Citations

This map shows the geographic impact of Daniel G. Arkfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel G. Arkfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel G. Arkfeld more than expected).

Fields of papers citing papers by Daniel G. Arkfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel G. Arkfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel G. Arkfeld. The network helps show where Daniel G. Arkfeld may publish in the future.

Co-authorship network of co-authors of Daniel G. Arkfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel G. Arkfeld. A scholar is included among the top collaborators of Daniel G. Arkfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel G. Arkfeld. Daniel G. Arkfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arkfeld, Daniel G., et al.. (2025). Scurvy in a Patient with Crohn's Disease: A Case Report. Current Rheumatology Reviews. 21. 1 indexed citations
2.
Arkfeld, Daniel G., et al.. (2024). A Rare Presentation of Cryoglobulinemic Vasculitis Associated with Primary Sjögren’s Syndrome. Current Rheumatology Reviews. 21(4). 480–486.
3.
Arkfeld, Daniel G., et al.. (2023). Clinical Image: Eczema herpeticum in a patient with rheumatoid arthritis and dry eye syndrome. ACR Open Rheumatology. 6(3). 137–137.
4.
Karri, Jay, et al.. (2021). Chronic Pain in Patients with Rheumatoid Arthritis. Current Pain and Headache Reports. 25(9). 59–59. 35 indexed citations
5.
Wise, Leanna & Daniel G. Arkfeld. (2019). A patient with primary Sjogren’s syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: a case-based review. Clinical Rheumatology. 39(4). 1357–1362. 6 indexed citations
6.
Matcuk, George R., et al.. (2019). Linear Morphea With Inflammatory Myositis. The Journal Of Hand Surgery. 45(8). 782.e1–782.e5.
7.
Johnson, Jennifer, et al.. (2015). Rheumatologic manifestations of the “MonoMAC” syndrome. a systematic review. Clinical Rheumatology. 34(9). 1643–1645. 4 indexed citations
8.
Arkfeld, Daniel G., et al.. (2015). Priapism after tumor necrosis factor alpha inhibitor use. Clinical Rheumatology. 34(4). 801–802. 9 indexed citations
9.
Escalante, Patricio, Rizwana Khan, San San Aye, et al.. (2014). Diagnosis of Latent Tuberculosis Infection with T-SPOT®.TB in a Predominantly Immigrant Population with Rheumatologic Disorders. Lung. 193(1). 3–11. 6 indexed citations
10.
Hamm‐Alvarez, Sarah F., Srikanth Reddy Janga, Maria C. Edman, et al.. (2014). Tear Cathepsin S as a Candidate Biomarker for Sjögren's Syndrome. Arthritis & Rheumatology. 66(7). 1872–1881. 99 indexed citations
11.
Metyas, Samy, et al.. (2010). Pregnancy in a Patient With Gouty Arthritis Secondary to Pseudo-Bartter Syndrome. JCR Journal of Clinical Rheumatology. 16(5). 219–220. 4 indexed citations
12.
Arkfeld, Daniel G. & Ilene C. Weitz. (2009). Immune Thrombocytopenia in Patients with Connective Tissue Disorders and the Antiphospholipid Antibody Syndrome. Hematology/Oncology Clinics of North America. 23(6). 1239–1249. 11 indexed citations
13.
Metyas, Samy, Rafik Tadros, & Daniel G. Arkfeld. (2008). Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis. Rheumatology International. 29(4). 437–439. 28 indexed citations
14.
Oliveira, Bruno, et al.. (2007). Successful Rituximab Therapy of Acquired Factor VIII Inhibitor in a Patient With Rheumatoid Arthritis. JCR Journal of Clinical Rheumatology. 13(2). 89–91. 16 indexed citations
15.
Arkfeld, Daniel G.. (2007). The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatology International. 28(3). 205–215. 35 indexed citations
16.
Arkfeld, Daniel G. & Edward Rubenstein. (2005). Quest for the Holy Grail to cure arthritis and osteoporosis: Emphasis on bone drug delivery systems. Advanced Drug Delivery Reviews. 57(7). 939–944. 10 indexed citations
17.
Hendifar, Andrew, et al.. (2005). Myositis ossificans: A case report. Arthritis Care & Research. 53(5). 793–795. 9 indexed citations
18.
Metyas, Samy, Daniel G. Arkfeld, Deborah M. Forrester, & Glenn R. Ehresmann. (2004). Infliximab Treatment of Familial Mediterranean Fever and Its Effect on Secondary AA Amyloidosis. JCR Journal of Clinical Rheumatology. 10(3). 134–137. 37 indexed citations
19.
Wang, Wei, et al.. (2002). Differential MHC Class II-Mediated Presentation of Rheumatoid Arthritis Autoantigens by Human Dendritic Cells and Macrophages. The Journal of Immunology. 169(11). 6625–6633. 78 indexed citations
20.
Liebling, Michael R., et al.. (1994). Identification of neisseria gonorrhoeae in synovial fluid using the polymerase chain reaction. Arthritis & Rheumatism. 37(5). 702–709. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Taglietti Breakdown of academic impact, for papers by Joëlle Goetz Breakdown of academic impact, for papers by Cor L. Verweij Breakdown of academic impact, for papers by Hirotsugu Ide Breakdown of academic impact, for papers by O Hübscher Breakdown of academic impact, for papers by Laëtitia Le Pottier Breakdown of academic impact, for papers by Thomas McDonnell Breakdown of academic impact, for papers by Nancy Solowski Breakdown of academic impact, for papers by Guadalupe Lima Breakdown of academic impact, for papers by Daniel Aeberli
Rankless by CCL
2026